Insulin Sensitivity and Gynaecological Features of Infertile Cameroonian Females with Polycystic Ovary Syndrome: A Cross-Sectional Study
Open Journal of Obstetrics and Gynecology · 2017 · 07 (13) · 1247-1254
DOI: 10.4236/ojog.2017.713127 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Open Journal of Obstetrics and Gynecology, 2017. Verfasst von Julius Sama Dohbit und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS), characterized by ovulatory dysfunction, polycystic ovary(PCO),hyperandrogenism and insulin resistance is the commonest endocrine disorder in women of reproductive age. It is an intriguing pathology that involves the perpetuation of a vicious circle with reproductive, endocrine and metabolic components. We aimed to assess the reproductive features and insulin sensitivity (IS) in infertile women with or without PCOS. Materials and Methods: We carried out a cross-sectional analytic study at the outpatient Obstetrics and Gynaecology Department of the Yaounde Gyneco-obstetric and Pediatrics Hospital, Cameroon from September 1st 2012 to March 31st 2013 giving total study duration of 07 months. Laboratory analyses were carried out at the National Obesity Centre(NOC)of the Yaounde Central Hospital, Cameroon.
Results
Overall, 36 infertile females were enrolled, which included 15 diagnosed cases of PCOS according to Rotterdam consensus meeting of 2003 and 21 non PCOS subjects as control. PCOS women were younger than non PCOS women (28.8 ± 5.5 vs. 35.0 ± 4.2 years; p = 0.0004). The majority of the women in the PCOS group were spaniomenorrheic (11/15), and ultrasonographic findings were typical of PCOS. Hirsutism score was higher in the PCOS group with a median of 9 (7 - 13). Insulin sensitivity was impaired in two-thirds of the study population, with 12 women found to be insulin resistant(6 PCOS, 6 non PCOS), 12 patients had intermediate insulin sensitivity(2 PCOS, 10 non PCOS)and 12 insulin sensitive(7 PCOS, 5 non PCOS). Apart from blood glucose levels (p = 0.007), all other anthropometric and biological parameters were not significant. Spearman’s correlation identified fasting plasma glucose and total cholesterol as factors associated with insulin sensitivity in females with PCOS. Impaired fasting glucose was observed in 13 patients with 08 from the PCOS group.
Conclusion
We conclude that young age, spaniomenorrhea and hirsutism are common findings in PCOS. Furthermore, our findings suggest that PCOS may be more of systemic metabolic disease than solely a purely gynecologic disorder as described hitherto. Despite normal fasting plasma glucose levels, a good proportion of these women has impaired insulin sensitivity and it is associated with a metabolic syndrome.
Zitieren
APA
Dohbit, J. S., Sobngwi, E., Kemfang, J. D., Foumane, P., Tochie, J. N., Elong, F. A., Bate, B., & Mboudou, E. T. (2017). Insulin Sensitivity and Gynaecological Features of Infertile Cameroonian Females with Polycystic Ovary Syndrome: A Cross-Sectional Study. Open Journal of Obstetrics and Gynecology, 07(13), 1247-1254. https://doi.org/10.4236/ojog.2017.713127
Vancouver
Dohbit JS, Sobngwi E, Kemfang JD, Foumane P, Tochie JN, Elong FA, et al. Insulin Sensitivity and Gynaecological Features of Infertile Cameroonian Females with Polycystic Ovary Syndrome: A Cross-Sectional Study. Open Journal of Obstetrics and Gynecology. 2017;07(13):1247-1254. doi:10.4236/ojog.2017.713127
BibTeX
@article{Dohbit2017,
author = {Dohbit, Julius Sama and Sobngwi, Eugene and Kemfang, Jean Dupont and Foumane, Pascal and Tochie, Joel Noutakdie and Elong, Felix A. and Bate, Betsy and Mboudou, Emile T.},
title = {Insulin Sensitivity and Gynaecological Features of Infertile Cameroonian Females with Polycystic Ovary Syndrome: A Cross-Sectional Study},
journal = {Open Journal of Obstetrics and Gynecology},
year = {2017},
volume = {07},
number = {13},
pages = {1247--1254},
doi = {10.4236/ojog.2017.713127}
}
EUVIMED